Type 1 Interferons Induce Changes in Core Metabolism that Are Critical for 
Immune Function

Wu, Duojiao; Sanin, David E.; Everts, Bart; Chen, Qiongyu; Qiu, Jing; Buck, Michael D.; Patterson, Annette; Smith, Amber M.; Chang, Chih-Hao; Liu, Zhiping; Artyomov, Maxim N.; Pearce, Edward J.; Cella, Marina; Pearce, Edward J.

doi:org/10.1016/j.immuni.2016.06.006

Datensatz

DATENSATZ AKTIONENEXPORT

Zur Ablage hinzufügen

Lokale TagsFreigabegeschichteDetailsÜbersicht

Freigegeben

Zeitschriftenartikel

Type 1 Interferons Induce Changes in Core Metabolism that Are Critical for Immune Function

MPG-Autoren

Artyomov, Maxim N.
Department Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

/persons/resource/persons201435

Pearce, Edward J.
Department Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

/persons/resource/persons201435

Pearce, Edward J.
Department Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

Externe Ressourcen

https://www.sciencedirect.com/science/article/pii/S1074761316302096?via%3Dihub
(Verlagsversion)

Volltexte (beschränkter Zugriff)

Für Ihren IP-Bereich sind aktuell keine Volltexte freigegeben.

Volltexte (frei zugänglich)

Es sind keine frei zugänglichen Volltexte in PuRe verfügbar

Ergänzendes Material (frei zugänglich)

Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar

Zitation

Wu, D., Sanin, D. E., Everts, B., Chen, Q., Qiu, J., Buck, M. D., et al. (2016). Type 1 Interferons Induce Changes in Core Metabolism that Are Critical for Immune Function. Immunity, 44, 1325-1326. doi:org/10.1016/j.immuni.2016.06.006.

Zitierlink: https://hdl.handle.net/21.11116/0000-0006-49B7-A

Zusammenfassung

Greater understanding of the complex host responses induced by type 1 interferon (IFN) cytokines could allow new therapeutic approaches for diseases in which these cytokines are implicated. We found that in response to the Toll-like receptor-9 agonist CpGA, plasmacytoid dendritic cells (pDC) produced type 1 IFNs, which, through an autocrine type 1 IFN receptor-dependent pathway, induced changes in cellular metabolism characterized by increased fatty acid oxidation (FAO) and oxidative phosphorylation (OXPHOS). Direct inhibition of FAO and of pathways that support this process, such as fatty acid synthesis, prevented full pDC activation. Type 1 IFNs also induced increased FAO and OXPHOS in non-hematopoietic cells and were found to be responsible for increased FAO and OXPHOS in virus-infected cells. Increased FAO and OXPHOS in response to type 1 IFNs was regulated by PPARα. Our findings reveal FAO, OXPHOS and PPARα as potential targets to therapeutically modulate downstream effects of type 1 IFNs.